Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 10, 2021

SELL
$478.3 - $607.98 $172,666 - $219,480
-361 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$544.75 - $658.21 $81,712 - $98,731
-150 Reduced 29.35%
361 $202,000
Q2 2020

Aug 14, 2020

SELL
$493.32 - $643.92 $333,484 - $435,289
-676 Reduced 56.95%
511 $319,000
Q1 2020

May 13, 2020

BUY
$336.18 - $494.43 $399,045 - $586,888
1,187 New
1,187 $580,000
Q2 2019

Aug 15, 2019

SELL
$299.6 - $414.82 $414,346 - $573,696
-1,383 Closed
0 $0
Q1 2019

May 10, 2019

BUY
$372.08 - $439.57 $103,438 - $122,200
278 Added 25.16%
1,383 $568,000
Q4 2018

Feb 13, 2019

SELL
$335.82 - $403.04 $320,036 - $384,097
-953 Reduced 46.31%
1,105 $413,000
Q3 2018

Nov 09, 2018

BUY
$351.14 - $408.51 $116,929 - $136,033
333 Added 19.3%
2,058 $832,000
Q2 2018

Aug 06, 2018

BUY
$284.6 - $344.99 $58,343 - $70,722
205 Added 13.49%
1,725 $595,000
Q1 2018

May 04, 2018

BUY
$315.82 - $393.78 $480,046 - $598,545
1,520 New
1,520 $523,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $81.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Bank Of Hawaii Portfolio

Follow Bank Of Hawaii and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Hawaii, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Hawaii with notifications on news.